Decitabine for treatment of myelodysplastic syndrome in an elderly patient and review of literature / 南方医科大学学报
Journal of Southern Medical University
;
(12): 280-282, 2012.
Artículo
en Chino
| WPRIM
| ID: wpr-267616
ABSTRACT
Findings in epigenetic changes in meylodysplastic syndromes (MDS) and the development of demethylating drugs provide a new approach to the treatment of MDS. We used standard-dose decitabine for treatment of MDS in an elderly patient with an International Prostate Symptom Score (IPSS) of moderate risk group 2, and achieved a complete response in the first course. We report our experience with this case and review the relevant literatures.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Azacitidina
/
Síndromes Mielodisplásicos
/
Metilasas de Modificación del ADN
/
Usos Terapéuticos
/
Quimioterapia
Límite:
Femenino
/
Humanos
Idioma:
Chino
Revista:
Journal of Southern Medical University
Año:
2012
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS